- Country: USA
- Summary: Rituximab and Biosimilars
- UST Ref No: 113898244
- Deadline: 14 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 36E79725R0021
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0021 for an unrestrictive procurement for Rituximab for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BoP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted item. The contract period will be for one year plus four pre-priced one-year option periods. The contract item(s) will be distributed through the VA s Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation 36E79725R0021 will be electronically issued in commercial product format in accordance with FAR Part 12 on or about February 17, 2025, with a tentative closing date of March 4, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to: Deborah.Fassl@va.gov. The estimated annual requirement is as follows:ITEMDESCRIPTIONPKG SIZE(ML per Vials)TOTAL ESTIMATED ANNUAL USAGE(Vials)1RITUXIMAB 10MG/ML AND BIOSIMILARS*1017,8582RITUXIMAB 10MG/ML AND BIOSIMILARS*5025,111*Proposed biosimilar products must be biological prod... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRituximab and Biosimilars - USA Tender
The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Rituximab and Biosimilars. This tender is published on USARFP under UST Ref No: 113898244 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
